T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.76B |
| 2 |
Cigna
CI
|
+$1.44B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.26B |
| 4 |
Occidental Petroleum
OXY
|
+$763M |
| 5 |
Danaher
DHR
|
+$762M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$2.46B |
| 2 |
Wynn Resorts
WYNN
|
+$1.11B |
| 3 |
Netflix
NFLX
|
+$1.03B |
| 4 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$975M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$909M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.87% |
| 2 | Financials | 13.64% |
| 3 | Consumer Discretionary | 13.54% |
| 4 | Industrials | 10.67% |
| 5 | Technology | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
SS&C Technologies
SSNC
$18.7B
| $972M | 0.2% |
31,119,076
+15,099,520
| +94% | +$463M |
|
127
Mattel
MAT
$4.29B
| $970M | 0.2% |
37,746,158
+8,840,931
| +31% | +$233M |
|
128
Chipotle Mexican Grill
CMG
$40.5B
| $958M | 0.2% |
79,161,700
+3,985,450
| +5% | +$50.4M |
|
129
Kohl's
KSS
$2.1B
| $945M | 0.19% |
15,096,843
-313,298
| -2% | -$21.8M |
|
|
ALTR
130
DELISTED
Altera Corp
ALTR
| $944M | 0.19% |
18,431,098
-3,513,335
| -16% | -$164M |
|
131
Estee Lauder
EL
$31.8B
| $934M | 0.19% |
10,774,208
+171,318
| +2% | +$14.8M |
|
|
HES
132
DELISTED
Hess
HES
| $925M | 0.19% |
13,837,234
+275,979
| +2% | +$19.6M |
|
133
Weyerhaeuser
WY
$18B
| $908M | 0.19% |
28,835,600
-5,882,858
| -17% | -$189M |
|
134
Simon Property Group
SPG
$71.2B
| $894M | 0.18% |
5,167,316
+78,013
| +2% | +$14.3M |
|
135
Procter & Gamble
PG
$338B
| $870M | 0.18% |
11,125,821
-162,109
| -1% | -$13M |
|
136
Henry Schein
HSIC
$9.94B
| $870M | 0.18% |
15,616,042
+58,109
| +0.4% | +$3.21M |
|
137
Fidelity National Financial
FNF
$12.8B
| $869M | 0.18% |
33,841,023
+334,528
| +1% | +$8.64M |
|
138
Canadian Pacific Kansas City
CP
$80.8B
| $868M | 0.18% |
27,100,280
+17,403,015
| +179% | +$621M |
|
|
RAD
139
DELISTED
Rite Aid Corporation
RAD
| $862M | 0.18% |
5,161,142
-265,837
| -5% | -$44.6M |
|
140
International Paper
IP
$22.1B
| $862M | 0.18% |
19,125,291
-2,208,071
| -10% | -$109M |
|
141
Ross Stores
ROST
$80.8B
| $860M | 0.18% |
17,685,630
-88,702
| -0.5% | -$4.46M |
|
142
Ashland
ASH
$3.42B
| $828M | 0.17% |
13,887,747
+20,985
| +0.2% | +$1.31M |
|
143
Willis Towers Watson
WTW
$31.8B
| $821M | 0.17% |
6,609,096
+121,584
| +2% | +$15.5M |
|
144
IDEX
IEX
$17.5B
| $821M | 0.17% |
10,444,424
+364,602
| +4% | +$28.2M |
|
145
Applied Materials
AMAT
$417B
| $816M | 0.17% |
42,459,106
+1,150,988
| +3% | +$23.6M |
|
|
XEC
146
DELISTED
CIMAREX ENERGY CO
XEC
| $814M | 0.17% |
7,378,962
+3,166,662
| +75% | +$378M |
|
147
Mondelez International
MDLZ
$78.9B
| $802M | 0.17% |
19,501,092
+2,562,071
| +15% | +$100M |
|
148
NiSource
NI
$20.1B
| $800M | 0.16% |
44,643,031
-13,508,936
| -23% | -$240M |
|
149
IBM
IBM
$225B
| $793M | 0.16% |
5,096,592
-74,841
| -1% | -$12M |
|
150
Illinois Tool Works
ITW
$83.5B
| $773M | 0.16% |
8,422,058
-1,145,909
| -12% | -$109M |
|
Similar funds
T. Rowe Price Associates's Q2 2015 Portfolio in Review
As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
- T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
- T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
- T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
- T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
- T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
- T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.
Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.